Targeting PI3K/Akt signal transduction for cancer therapy.
He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. · 2021
Read Targeting PI3K/Akt signal transduction for cancer therapy. by He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8677728.txt.
Description
He and co-authors review the PI3K/Akt signal pathway as a target for cancer therapy. This pathway drives many cell processes and is switched on too often in tumors. That overuse helps cancers start and grow. The team examined the nodes above and below the pathway to map its full role.
Drugs that block parts of the pathway have been widely tested. Their clinical gains stay limited so far. Tumors activate the pathway by many routes, and resistance often follows. The authors favor pairing pathway blockers with standard cancer care. They also review the state of each drug class. The strategy aims to break tumor survival routes more fully.
Catalog record
| CREATOR | He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 124 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |